Antitrust & Federal Regulatory

Mergers & Acquisitions Antitrust

Along with advising you on how best to achieve your goals, we can advise you on developing a deal structure that avoids antitrust concerns or responds to those already raised. Our attorneys are actively involved in highly antitrust sensitive transactions in a multitude of industries, including some of the more prominent and highly regulated industries in our economy, ranging from small to multibillion-dollar transactions. We are experienced in analyzing clients’ competitive environments quickly and coming up with a solid plan of attack to position transactions from the antitrust perspective and resolve issues as efficiently as possible.

We provide antitrust counseling and analysis on transactions and business practices, including acquisitions, divestitures, and joint ventures. We can also advise you on relations with competitors, suppliers, and customers as well as on licensing and distribution relationships. We have helped our clients’ mergers and acquisitions withstand the scrutiny of the Department of Justice (DOJ), Federal Trade Commission (FTC), Federal Communications Commission (FCC), and competition agencies around the world.

Quick Facts


  • Industry experience and established relationships with antitrust and industry regulators
  • Effectively challenged governmental decisions in court and in administrative proceedings
  • Represent large public companies, not-for-profits, start-ups, and domestic and international joint ventures
  • Attorneys who have held key positions at antitrust enforcement agencies

Areas of Focus

  • Antitrust counseling
  • Antitrust litigation
  • Competitor collaborations
  • Federal regulation
  • Government investigations
  • Hart-Scott-Rodino merger approval process
  • Mergers and acquisitions

Rankings & Recognitions

  • Attorneys recognized by Chambers USA, Best Lawyers, and Super Lawyers
  • Nightingale’s Healthcare News: Practice Chair named “Outstanding Healthcare Antitrust Lawyer” for several years in a row

Representative Experience

  • Represented CVS in the antitrust aspects of its $2.7 billion acquisition of Longs Drugs.
  • Represented CVS in the antitrust aspects of its $27 billion acquisition of Caremark.
  • Represented QIAGEN NV in its $1.6 billion acquisition of Digene Corporation, including antitrust aspects of the transaction.
  • Represented a cable company in the first successful FTC clearance of the acquisition of an overbuilt cable system.
  • Represented a national book publisher before the DOJ in its successful $3.5 billion acquisition of educational publishing assets.
  • Represented an energy company in a FTC investigation of its $1.1 billion acquisition of a financial interest in another energy company.
  • Represented a software company in the multi-jurisdictional merger review of its $219 million transaction with another software and equipment supplier.
  • Represented an international manufacturer of liquid analytical instruments before the DOJ in its merger with a national manufacturer of water analytical instrumentation.

Representative Clients

  • CVS Health Corporation
  • Partners HealthCare System, Inc.
  • Fierce Health Payer Highmark-West Penn Merger Sets Precedent for Payer-Provider Deals Farrah Short discuss the implications of vertical mergers between hospitals and health insurers and explain the reasons why the antitrust agency cleared the Highmark-West Penn merger.